Chemoinformaics analysis of Mauritine A N-Oxide
| Molecular Weight | 591.709 | nRot | 7 |
| Heavy Atom Molecular Weight | 550.381 | nRig | 31 |
| Exact Molecular Weight | 591.306 | nRing | 5 |
| Solubility: LogS | -1.058 | nHRing | 3 |
| Solubility: LogP | 0.364 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 41 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 91.0905 |
| nHD | 3 | BPOL | 51.7675 |
| QED | 0.373 |
| Synth | 5.914 |
| Natural Product Likeliness | 1.105 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.939 |
| Pgp-sub | 0.965 |
| HIA | 0.995 |
| CACO-2 | -5.498 |
| MDCK | 0.0000072 |
| BBB | 0.111 |
| PPB | 0.596583 |
| VDSS | 0.561 |
| FU | 0.4679 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.066 |
| CYP2c19-inh | 0.081 |
| CYP2c19-sub | 0.132 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.725 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.266 |
| CYP3a4-inh | 0.724 |
| CYP3a4-sub | 0.358 |
| CL | 3.933 |
| T12 | 0.914 |
| hERG | 0.009 |
| Ames | 0.045 |
| ROA | 0.824 |
| SkinSen | 0.014 |
| Carcinogencity | 0.373 |
| EI | 0.004 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.927552 |